We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $133B
1-Year Est. Return 43.5%
This Fund
S&P 500
This Quarter Est. Return
+14.19%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$117B
AUM Growth
+$9.87B
Cap. Flow
-$1.11B
Cap. Flow %
-0.95%
Top 10 Hldgs %
30.52%
Holding
4,391
New
216
Increased
2,182
Reduced
1,537
Closed
202

Top Buys

Rank Stock Value
1
COF icon
Capital One
COF
+$89.2M
2
FLUT icon
Flutter Entertainment
FLUT
+$43.9M
3
OKTA icon
Okta
OKTA
+$32.1M
4
CHWY icon
Chewy
CHWY
+$31.8M
5
COIN icon
Coinbase
COIN
+$26.9M

Sector Composition

Rank Sector Weight
1 Technology 31.83%
2 Financials 13.86%
3 Consumer Discretionary 10.91%
4 Healthcare 9.41%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ULCC icon
2651
Frontier Group Holdings
ULCC
$1.57B
$428K ﹤0.01%
117,984
+7,791
+7% +$28.5K
LOGI icon
2652
Logitech
LOGI
$15B
$426K ﹤0.01%
4,732
+152
+3% +$12.3K
SVV icon
2653
Savers
SVV
$1.67B
$425K ﹤0.01%
41,623
+9,410
+29% +$92.1K
FNLC icon
2654
First Bancorp
FNLC
$401M
$423K ﹤0.01%
16,666
+632
+4% +$15.3K
TDK
2655
DELISTED
TDK CORP AMER DEP SH
TDK
$423K ﹤0.01%
36,253
+864
+2% +$10.1K
WTI icon
2656
W&T Offshore
WTI
$546M
$419K ﹤0.01%
253,878
-45,595
-15% -$67.2K
PHLT
2657
DELISTED
Performant Healthcare Inc
PHLT
$418K ﹤0.01%
104,383
+8,937
+9% +$25.3K
IBEX icon
2658
IBEX
IBEX
$482M
$417K ﹤0.01%
14,320
+1,466
+11% +$39.2K
MGTX icon
2659
MeiraGTx Holdings
MGTX
$1.17B
$415K ﹤0.01%
63,715
+5,488
+9% +$32.4K
TMCI icon
2660
Treace Medical Concepts
TMCI
$293M
$415K ﹤0.01%
70,638
+722
+1% +$4.7K
EVEX icon
2661
Eve Holding
EVEX
$976M
$415K ﹤0.01%
60,480
+25,257
+72% +$113K
PINE
2662
Alpine Income Property Trust
PINE
$347M
$415K ﹤0.01%
28,181
+7,529
+36% +$116K
NPCE icon
2663
Neuropace
NPCE
$498M
$412K ﹤0.01%
36,956
+19,729
+115% +$247K
NEWT icon
2664
NewtekOne
NEWT
$378M
$411K ﹤0.01%
36,433
+2,108
+6% +$22.5K
AURA icon
2665
Aura Biosciences
AURA
$791M
$409K ﹤0.01%
65,407
+1,369
+2% +$8.01K
VNDA icon
2666
Vanda Pharmaceuticals
VNDA
$304M
$408K ﹤0.01%
86,546
+647
+0.8% +$2.83K
ZIMV
2667
DELISTED
ZimVie
ZIMV
$408K ﹤0.01%
43,664
+1,232
+3% +$11.3K
PLSE icon
2668
Pulse Biosciences
PLSE
$3.2B
$408K ﹤0.01%
27,048
-327
-1% -$5.43K
TNXP icon
2669
Tonix Pharmaceuticals
TNXP
$214M
$406K ﹤0.01%
11,298
-2,372
-17% -$62.2K
SWIM icon
2670
Latham Group
SWIM
$889M
$406K ﹤0.01%
63,639
+1,672
+3% +$9.72K
ATXS
2671
DELISTED
Astria Therapeutics
ATXS
$406K ﹤0.01%
75,674
+11,663
+18% +$56.5K
QTRX icon
2672
Quanterix
QTRX
$135M
$403K ﹤0.01%
60,629
+4,094
+7% +$22.8K
FET icon
2673
Forum Energy Technologies
FET
$927M
$403K ﹤0.01%
20,686
+1,781
+9% +$28.8K
MVBF icon
2674
MVB Financial
MVBF
$397M
$400K ﹤0.01%
17,765
+349
+2% +$6.45K
ACRE
2675
Ares Commercial Real Estate
ACRE
$264M
$400K ﹤0.01%
83,886
+5,107
+6% +$22.7K

Similar funds

RhumbLine Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, RhumbLine Advisers held 4,391 positions worth $117B, up 9.2% from $107B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

RhumbLine Advisers's Q2 2025 filing shows 216 new, 2,182 increased, 1,537 reduced and 202 closed positions. Its largest new stake was Ralliant Corp: 320,982 shares worth $15.6M. The largest sale was Discover Financial Services, an estimated $91M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q2 2025 buy was Ralliant Corp: 320,982 shares worth $15.6M.
  • RhumbLine Advisers added most to Capital One in Q2 2025, an estimated $89.2M increase.
  • RhumbLine Advisers's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $75.5M.
  • RhumbLine Advisers fully exited Discover Financial Services in Q2 2025, selling an estimated $91M.
  • RhumbLine Advisers's ten largest holdings make up 31% of its $117B portfolio in Q2 2025.
  • RhumbLine Advisers opened 216 new positions and closed 202 in Q2 2025.
  • RhumbLine Advisers's portfolio value rose 9.2% quarter-over-quarter to $117B.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.